The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

Provincial health dept launches adaptation plan; CM aide says it serves as a policy framework to address climate-related ...

A new study conducted during the first-ever reactive use of the Hecolin vaccine in South Sudan showed that a two-dose regimen ...

New discovery reveals an entire new world smaller than viruses and bacteria.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2024 financial results and 2025 ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

Egypt’s Minister of Health and Population Khaled Abdel Ghaffar announced that the country has met the regional target for ...

Hepatitis A vaccinations are being offered to children and staff at a school and nursery in Peterborough after a ‘small number of cases’ were detected. The vaccinations are being offered at Oakdale ...

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...